Head to head
Biorxiv vs Case Studies
Same numbers we show everywhere else, lined up. Ratings come from users, the grade comes from our scanner, adoption comes from public registries.
No reviews yet
Search and retrieve bioRxiv and medRxiv preprints — by DOI, date interval, or keyword — via MCP.
Full listing
The short version
Neither has been reviewed yet, so the comparison rests on the scan and the public usage numbers. The safety scan favours Biorxiv (93/100 against 67). Biorxiv has noticeably more public adoption.
| Biorxiv | Case Studies | |
|---|---|---|
| User rating | No reviews yet | No reviews yet |
| Safety grade | A93/100 | C67/100 |
| Adoption | Growing | New |
| GitHub stars | 4 | – |
| Downloads / week | – | – |
| Runs where | Hosted (remote) | Hosted (remote) |
| Gateway-ready | Yes | Yes |
| Tools | 6 | 2 |
| Write actions | — | — |
| Price per call | Free | Free |
| Licence | NOASSERTION | — |
| Last release | 2026-09-19 | — |
| Category | SEO | SEO |